(Axios) – The Biden administration this week is hosting a first-of-its-kind international summit about the use of artificial intelligence in the life sciences as governments and private industry increasingly push the boundaries of biotechnology. Why it matters: The convergence of the life sciences and advanced AI could reveal the underpinnings of diseases, help identify new cures or produce more resistant crops. But thereare barriers and bottlenecks — and potential risks — to combining the technologies. (Read More)